1. Current and future treatment options in osteoporosis

   • Linda Brewer
   • David Williams
   • Alan Moore

   Review Article 16 February 2011 Pages: 321 - 331

   

2. Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)

   • Natig Gassanov
   • Nasser Semmo
   • Fikret Er

   Review Article 17 February 2011 Pages: 333 - 346

   

3. Genistein alters caffeine exposure in healthy female volunteers

   • Yao Chen
   • Chang-Qiong Xiao
   • Hong-Hao Zhou

   Clinical Trial 14 December 2010 Pages: 347 - 353

   

4. Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers

   • Arun Nair
   • Lorna McKinlay
   • Brian J. Lipworth

   Clinical Trial 15 January 2011 Pages: 355 - 363

   

5. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers

   • Pamela S. Silva
   • Vanessa Fontana
   • Jose Eduardo Tanus-Santos

   Pharmacodynamics 09 February 2011 Pages: 365 - 370

   

6. Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters

   • Christof Geisen
   • Beate Luxembourg
   • Johannes Oldenburg

   Pharmacogenetics Open access 26 November 2010 Pages: 371 - 381

   

7. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia

   • I-Ching Lai
   • Geng-Han Mo
   • Ying-Jay Liou

   Pharmacogenetics 22 December 2010 Pages: 383 - 388

8. The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study

   • Miodrag C. Ostojic
   • Zoran Perisic
   • on behalf of the Stealth PK Investigators

   Pharmacokinetics and Disposition 09 October 2010 Pages: 389 - 398

   

9. Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate

   • Maria Cusato
   • Massimo Allegri
   • Mario Regazzi

   Pharmacokinetics and Disposition 16 November 2010 Pages: 399 - 406

   

10. Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study

    • Elisabetta Poluzzi
    • Carlo Piccinni
    • Nicola Montanaro

    Pharmacoepidemiology and Prescription 09 December 2010 Pages: 407 - 414

    

11. Understanding adherence to therapeutic guidelines: a multilevel analysis of statin prescription in the Skaraborg Primary Care Database

    • Per Hjerpe
    • Henrik Ohlsson
    • Juan Merlo

    Pharmacoepidemiology and Prescription 29 December 2010 Pages: 415 - 423

    

12. Contribution of pH to systemic exposure of niflumic acid following oral administration of talniflumate

    • Eunyoung Kim
    • Wonku Kang

    Short Communication 17 February 2011 Pages: 425 - 428

    

13. Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding

    • Dario Cattaneo
    • Paola Meraviglia
    • Emilio Clementi

    Letter to the Editors 03 November 2010 Pages: 429 - 431